Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.
Standard
Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. / Rades, Dirk; Kuhn, Hildegard; Schultze, Juergen; Homann, Nils; Brandenburg, Bernd; Schulte, Rainer; Krüll, Andreas; Schild, Steven E; Dunst, Juergen.
In: INT J RADIAT ONCOL, Vol. 70, No. 4, 4, 2008, p. 1087-1093.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.
AU - Rades, Dirk
AU - Kuhn, Hildegard
AU - Schultze, Juergen
AU - Homann, Nils
AU - Brandenburg, Bernd
AU - Schulte, Rainer
AU - Krüll, Andreas
AU - Schild, Steven E
AU - Dunst, Juergen
PY - 2008
Y1 - 2008
N2 - PURPOSE: To investigate potential prognostic factors, including hemoglobin levels before and during radiotherapy, for associations with survival and local control in patients with unirradiated locally recurrent rectal cancer. PATIENTS AND METHODS: Ten potential prognostic factors were investigated in 94 patients receiving radiotherapy for recurrent rectal cancer: age (or=69 years), gender, Eastern Cooperative Oncology Group performance status (0-1 vs. 2-3), American Joint Committee on Cancer (AJCC) stage (50 Gy), and hemoglobin levels before (or=12 g/dL) and during (majority of levels: or=12 g/dL) radiotherapy. Multivariate analyses were performed, including hemoglobin levels, either before or during radiotherapy (not both) because these are confounding variables. RESULTS: Improved survival was associated with better performance status (por=12 g/dL both before (p=0.031) and during (por=12 g/dL before (p
AB - PURPOSE: To investigate potential prognostic factors, including hemoglobin levels before and during radiotherapy, for associations with survival and local control in patients with unirradiated locally recurrent rectal cancer. PATIENTS AND METHODS: Ten potential prognostic factors were investigated in 94 patients receiving radiotherapy for recurrent rectal cancer: age (or=69 years), gender, Eastern Cooperative Oncology Group performance status (0-1 vs. 2-3), American Joint Committee on Cancer (AJCC) stage (50 Gy), and hemoglobin levels before (or=12 g/dL) and during (majority of levels: or=12 g/dL) radiotherapy. Multivariate analyses were performed, including hemoglobin levels, either before or during radiotherapy (not both) because these are confounding variables. RESULTS: Improved survival was associated with better performance status (por=12 g/dL both before (p=0.031) and during (por=12 g/dL before (p
M3 - SCORING: Zeitschriftenaufsatz
VL - 70
SP - 1087
EP - 1093
JO - INT J RADIAT ONCOL
JF - INT J RADIAT ONCOL
SN - 0360-3016
IS - 4
M1 - 4
ER -